An open, multicenter, exploratory study of apatinib mesylate maintenance therapy for recurrent/metastatic head and neck squamous cell carcinoma (ChiCTR1800019375).
Jinlong WeiJing SuJianfeng WangXiaojing JiaQin ZhaoWeiyan ShiHuanhuan WangZhuangzhuang ZhengXin JiangPublished in: Head & neck (2024)
Maintenance therapy with apatinib is an effective and well-tolerated regimen in patients with R/M HNSCC.